as on September 17, 2025 at 9:41 pm IST
Day's Low
Day's High
1.43%
Downside
0.97%
Upside
52 Week's Low
52 Week's High
20.27%
Downside
244.41%
Upside
Check Viking Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.7B
EPS (TTM)
-2.3414
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
-0.03
EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
13303500.00%
Compare market cap, revenue, PE, and other key metrics of Viking Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.7B | 264.92% | NA | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Viking Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Viking Therapeutics, Inc. investment value today
Current value as on today
₹42,301
Returns
Returns from Viking Therapeutics, Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Viking Therapeutics, Inc.. Average target price of $92.29
Get share price movements and forecasts by analysts on Viking Therapeutics, Inc..
What analysts predicted
74.29%UPSIDE
Target Price
$92.29
Current Price
$23.73
Analyzed by
17 Analysts
Target
$92.29
Viking Therapeutics, Inc. target price $92.29, a slight upside of 74.29% compared to current price of $23.73. According to 17 analysts rating.
Investment in Viking Therapeutics, Inc. Shares on INDmoney has grown by 251.77% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:251.77% versus previous 30 day period
Search interest for Viking Therapeutics, Inc. Stock has increased by 119% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:119% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, VKTX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 130.5%
Price Dip
In the last 7 days, VKTX stock has moved down by -8.4%
Organisation | Viking Therapeutics, Inc. |
Headquarters | 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Dr. Brian Lian Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Brian Lian Ph.D. | President, CEO & Director |
Mr. Gregory S. Zante CPA, CPA | Chief Financial Officer |
Ms. Marianne Mancini | Chief Operating Officer |
Mr. Michael Morneau | Vice President of Finance & Administration |
Dr. Geoffrey E. Barker Ph.D. | Chief Development Officer |
Viking Therapeutics, Inc. share price today is $23.73 as on . Viking Therapeutics, Inc. share today touched a day high of $23.96 and a low of $23.39.
Viking Therapeutics, Inc. share touched a 52 week high of $81.73 on and a 52 week low of $18.92 on . Viking Therapeutics, Inc. stock price today i.e. is trending at $23.73,which is 70.97% down from its 52 week high and 25.42% up from its 52 week low.
Viking Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Viking Therapeutics, Inc. (VKTX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Viking Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Viking Therapeutics, Inc. share’s latest price of $23.73 as on September 17, 2025 at 9:41 pm IST, you will get 0.4214 shares of Viking Therapeutics, Inc.. Learn more about
fractional shares .
Viking Therapeutics, Inc. stock has given 264.92% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?